Acrylamide monomer

CAS No. 79-06-1

Acrylamide monomer( —— )

Catalog No. M20290 CAS No. 79-06-1

Acrylamide is a member of the class of acrylamides. It has a role as a carcinogenic agent a neurotoxin a mutagen an alkylating agent and a Maillard reaction product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Acrylamide monomer
  • Note
    Research use only, not for human use.
  • Brief Description
    Acrylamide is a member of the class of acrylamides. It has a role as a carcinogenic agent a neurotoxin a mutagen an alkylating agent and a Maillard reaction product.
  • Description
    Acrylamide is a member of the class of acrylamides. It has a role as a carcinogenic agent a neurotoxin a mutagen an alkylating agent and a Maillard reaction product.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    79-06-1
  • Formula Weight
    71.08
  • Molecular Formula
    C3H5NO
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:14 mg/mL (196.96 mM)
  • SMILES
    NC(=O)C=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • STC314

    STC314 is an anti-infective agent that reverses organ damage caused by excessive immune response by neutralizing extracellular histones and neutrophil trapping networks, and can be used in the study of sepsis and acute respiratory distress syndrome (ARDS).

  • VK-28

    VK-28 is a brain permeable iron chelator with neuroprotection. VK-28 inhibits basal as well as iron-induced mitochondrial lipid peroxidation.

  • 30-Hydroxygambogic a...

    30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines.